https://www.prnewswire.com/news-releases/uptake-of-biogens-tecfidera-and-increased-availability-of-merck-kgaas-mavenclad-fueling-significant-increase-in-oral-disease-modifying-therapy-share-of-multiple-sclerosis-patients-in-europe-to-the-detriment-of-tevas-copaxone-300727155.html
/PRNewswire/ -- Driven by the availability of Merck KGaA's Mavenclad and substantial uptake of Biogen's Tecfidera, the oral disease-modifying therapy (DMT)...
uptakebiogentecfideraincreasedavailability
https://www.mijnmedicijn.nl/centraal-zenuwstelsel/tecfidera
Tecfidera: 74 ervaringen met effect en bijwerkingen. Vrouw, 32: Ik zit nu in maand 5, inmiddels ook met zonodig maagbeschermers tegen de maagzuur en...
tecfideraen